Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Market Snippet By Vaccine Type
3.2. Market snippet By Virus type
3.3. Market Snippet By Age Group
3.4. Market Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Number of Government Investments
4.1.1.2. Robust R&D Investments with A Strong Pipeline
4.1.2. Restraints
4.1.2.1. High Cost of Vaccines
4.1.3. Opportunity
4.1.3.1. The immunization programs and camps are conducted by several medical organizations
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Vaccine Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
7.1.2. Market Attractiveness Index, By Vaccine Type
7.2. Quadrivalent*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Trivalent Vaccines
8. By Virus Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
8.1.2. Market Attractiveness Index, By Virus Type
8.2. Type A Influenza Virus *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Type B Influenza Virus
9. By Age Group
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.1.2. Market Attractiveness Index, By Age Group
9.2. Children*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Adult
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Spain
10.3.6.5. Italy
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
Australia
10.5.6.4. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vaccine Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Virus Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. AstraZeneca PLC*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. CSL Limited
12.3. Abbott Laboratories
12.4. F.Hoffmann-La Roche Ltd
12.5. Emergent BioSolutions
12.6. GlaxoSmithKline PLC
12.7. Gamma Vaccines Pvt. Ltd
12.8. Merck & Co. Inc.
12.9. Pfizer Inc.
12.10. Sanofi Pasteur SA
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us